MedPath

Accord Healthcare Inc.

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

75

FDA:75

Drug Approvals

Temozolomide

Approval Date
May 23, 2025
FDA

PEMETREXED

Approval Date
Mar 27, 2024
FDA

LISINOPRIL

Approval Date
Mar 13, 2024
FDA

FINGOLIMOD HYDROCHLORIDE

Approval Date
Feb 20, 2024
FDA

EZETIMIBE

Approval Date
Feb 15, 2024
FDA

Teriflunomide

Approval Date
Feb 15, 2024
FDA

Temsirolimus

Approval Date
Feb 15, 2024
FDA

Topotecan

Approval Date
Feb 15, 2024
FDA

Allopurinol

Approval Date
Feb 15, 2024
FDA

Mycophenolic Acid

Approval Date
Jan 17, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.